chr7-152654832-G-A
Variant summary
The NM_005431.2(XRCC2):c.122-5469C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene XRCC2 is a tumor suppressor gene (CancerMine: 2 TSG, 1 oncogene citations). The gene XRCC2 is a known oncogene (CancerMine: 2 TSG, 1 oncogene citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005431.2 intron
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group UInheritance: AR Classification: MODERATE, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, LiferaOmics
- male infertility with azoospermia or oligozoospermia due to single gene mutationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- premature ovarian failure 17Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- spermatogenic failure 50Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- familial ovarian cancerInheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 2 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_005431.2. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
XRCC2 | MANE Select | c.122-5469C>T | intron | Intron 2 of 2 | Prot: NP_005422.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
XRCC2 | TSL:1MANE Select | c.122-5469C>T | intron | Intron 2 of 2 | Prot: ENSP00000352271.1 UniProt: | |
XRCC2 | TSL:1 | n.144-5469C>T | intron | Intron 2 of 2 | Prot: | |
XRCC2 | c.-47-5469C>T | intron | Intron 1 of 1 | Prot: ENSP00000513758.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 4 sources | |||||
GnomAD3 genomes | Cov:33 | ||||
GnomAD4 genome | Cov:33 | ||||
TOPMed (Bravo) | AF: 0.0000151 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00 | AC:0 | Hom:42 | AN:22684 | |
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Benign | 5.5 | |
BayesDel_noAF | Benign | -0.86 | |
CADD | Benign | 4.5 | |
DANN | Benign | 0.59 | |
GPN-Star LLR | N/A | -2.1 | |
GPN-Star score | N/A | 2.1 | |
PhyloP100 | Benign | 0.90 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.